Atea Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Atea Pharmaceuticals

28/02/2022 23:19

* Atea Pharmaceuticals Inc  AVIR.OQ  reported quarterly
adjusted
earnings of $1.34​​ per share for the quarter ended in December.
The mean expectation of four analysts for the quarter was
for earnings of 17 cents per share.
    * Revenue rose 295.2% to $192.18 million from a year ago; 
analysts expected $85.73 million. 
    * Atea Pharmaceuticals Inc's reported EPS for the quarter
was
$1.34​.
    * The mean earnings estimate of analysts had risen by
about 400.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Atea Pharmaceuticals Inc shares had fallen by 28.7% this
quarter.
    * The company reported quarterly net income of $117.13
million.
    * Wall Street's median 12-month price target for Atea
Pharmaceuticals Inc is $8.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated February 28 at 11:19 p.m.
 ​All figures in US dollars unless otherwise stated